These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 25863450)
21. Sublingual immunotherapy: dosing in relation to clinical and immunological efficacy. Larenas-Linnemann DE Allergy Asthma Proc; 2008; 29(2):130-9. PubMed ID: 18430309 [TBL] [Abstract][Full Text] [Related]
22. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy. Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349 [No Abstract] [Full Text] [Related]
23. [Allergen specific immunotherapy: new approaches]. Tay F; Kündig TM; Senti G Praxis (Bern 1994); 2010 Oct; 99(21):1279-84. PubMed ID: 20960398 [TBL] [Abstract][Full Text] [Related]
24. Immunological mechanisms of allergen-specific immunotherapy. Larché M; Akdis CA; Valenta R Nat Rev Immunol; 2006 Oct; 6(10):761-71. PubMed ID: 16998509 [TBL] [Abstract][Full Text] [Related]
25. Sublingual immunotherapy and subcutaneous immunotherapy: issues in the United States. Greenberger PA; Ballow M; Casale TB; Platts-Mills TA; Sampson HA J Allergy Clin Immunol; 2007 Dec; 120(6):1466-8. PubMed ID: 17936891 [No Abstract] [Full Text] [Related]
26. [Specific immunotherapy in desensitization of allergic patients. Oral administration instead of injections? (interview by Andrea Warpakowski)]. Grevers G MMW Fortschr Med; 2003 May; 145(18):18. PubMed ID: 12808815 [No Abstract] [Full Text] [Related]
27. Allergen-specific immunotherapy: current concepts and future directions. Bieber T; Simon HU Allergy; 2011 Jun; 66(6):709-12. PubMed ID: 21518373 [No Abstract] [Full Text] [Related]
28. [Sublingual vs subcutaneous immunotherapy]. Olivé Pérez A Rev Alerg Mex; 2004; 51(1):29-35. PubMed ID: 15119753 [TBL] [Abstract][Full Text] [Related]
29. Progress in the development of specific immunotherapies for house dust mite allergies. Moingeon P Expert Rev Vaccines; 2014 Dec; 13(12):1463-73. PubMed ID: 25187166 [TBL] [Abstract][Full Text] [Related]
30. Local reactions from subcutaneous allergen immunotherapy. Coop CA Immunotherapy; 2013 Dec; 5(12):1339-45. PubMed ID: 24283844 [TBL] [Abstract][Full Text] [Related]
31. Specific immunotherapy with allergen mixes: what is the evidence? Nelson HS Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):549-53. PubMed ID: 19745727 [TBL] [Abstract][Full Text] [Related]
32. Allergen immunotherapy, routes of administration and cytokine networks: an update. Cuppari C; Leonardi S; Manti S; Filippelli M; Alterio T; Spicuzza L; Rigoli L; Arrigo T; Lougaris V; Salpietro C Immunotherapy; 2014; 6(6):775-86. PubMed ID: 25186606 [TBL] [Abstract][Full Text] [Related]
33. [Instead of hyposensitization by injection. Dissolving immunotherapy under the tongue?]. Klein F MMW Fortschr Med; 2007 Jan; 149(3):16. PubMed ID: 17632861 [No Abstract] [Full Text] [Related]
34. Sublingual immunotherapy of allergic diseases. Werner-Klein M; Kalkbrenner F; Erb KJ Expert Opin Drug Deliv; 2006 Sep; 3(5):599-612. PubMed ID: 16948556 [TBL] [Abstract][Full Text] [Related]
35. Multiallergen immunotherapy for allergic rhinitis and asthma. Nelson HS J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653 [TBL] [Abstract][Full Text] [Related]
36. Specific immunotherapy in children. Bufe A; Roberts G Clin Exp Allergy; 2011 Sep; 41(9):1256-62. PubMed ID: 21518041 [TBL] [Abstract][Full Text] [Related]